Table 2.
Intraperitoneal injections of XAV-939, LGK-974, and iCRT14 in rats
Name | Vehicle | Purpose | Dose and schedule |
---|---|---|---|
XAV-939 | 3% DMSO in 1% sodium carboxymethyl-cellulose (CMC) in PBS | Single analgesic effects | 0.3, 1, and 3 mg/kg on day 16 |
Extended analgesic effects | 3 mg/kg twice daily on days 16–19 | ||
Preventive effects | 3 mg/kg twice daily on days 6–14 | ||
LGK-974 | 1% DMSO in 1% CMC in PBS | Single analgesic effects | 0.5 and 2 mg/kg on day 16 |
Extended analgesic effects | 2 mg/kg twice daily on days 16–19 | ||
Preventive effects | 2 mg/kg twice daily on days 6–14 | ||
iCRT14 | 10% DMSO in 1% CMC in PBS | Single analgesic effects | 10 and 30 mg/kg on day 16 |